Myonex To Acquire Creapharm’s Clinical & Commercial Packaging And Bioservices Business

By Author: otis
Total Articles: 386
Comment this article

Myonex, a well-known global clinical trial supply company, has finalized an agreement to purchase Creapharm Group's Clinical Packaging & Distribution and Commercial Packaging business and bioservices. Creapharm, headquartered in Reims, France, with additional locations in Bordeaux and Bailly-Romainvilliers, France, as well as Marietta, Georgia, USA, will be part of this acquisition pending regulatory approvals.

This strategic move will merge the capabilities of both organizations to offer comprehensive services and exceptional client dedication. Myonex, recognized for its drug sourcing and clinical trial prescription services, will leverage Creapharm's proficiency in clinical packaging and distribution, along with its expertise in commercial packaging and advanced therapy medicinal products (ATMPs) supply chain management.

James Lovett, CEO of Myonex, expressed enthusiasm for the acquisition, highlighting the potential to address market needs swiftly and effectively. Eric Placet, CEO and Founder of Creapharm, views this acquisition as a chance to contribute packaging solutions and expertise to Myonex's operations, ...
... broadening the spectrum of services available to enhance more efficient, patient-centered clinical trials.

Mike Cohen, Co-Owner and Executive Chairman of Myonex, emphasized the synergies and shared values between the two companies. He stressed their joint commitment to social and environmental responsibility, ensuring the success of clients, clinical trial sites, and patients.

Read More - https://www.techdogs.com/tech-news/business-wire/myonex-to-acquire-creapharms-clinical-commercial-packaging-and-bioservices-business